An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
Completed
Conditions studied: Moderate to Severe Plaque Psoriasis
In brief
The purpose of the study is to develop a database containing patient-reported information that may be used to understand and to increase awareness of the impact that moderate-to-severe plaque psoriasis can have on both daily life and life in general from a patient's perspective. The database will include self-reported patient narratives on the topic of the experience of having moderate-to-severe plaque psoriasis and will include information on treatments received, as well as de-identified clinical photographs taken over the course of the disease.
Key facts
- Study ID
- NCT01555606
- Run by
- Janssen Biotech, Inc.
- People needed
- 108
- Starts
- 2011-06-01
- Expected to finish
- 2012-07-01
- Last updated by the study team
- 2015-07-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Adult male and female patients having diagnosis of plaque psoriasis for at least 6 months prior to screening
- Patients who are candidates for or are currently receiving the following: a. conventional systemic agents (eg, MTX, acitretin, cyclosporine, fumarates, or systemic psoralens plus ultraviolet A light [PUVA]), b. topical therapy and/or phototherapy (and are eligible for, but are not currently receiving oral systemic or biologic therapy), c. biologic therapy for moderate to severe plaque psoriasis
- Have a peak historical or current physician's global assessment (PGA) of greater than or equal to 3 (range 0-5)
- Patients must have the ability to read and speak English
- Patients must reside in the US.
You may not qualify if…
- Patients with guttate, erythrodermic, or pustular psoriasis (all are various types of psoriasis)
- Patients with serious concomitant illness that could require the use of systemic corticosteroids or otherwise interfere with the patient's participation in the trial
Where it is running
- Study site — Phoenix, Arizona, United States
- Study site — Sacramento, California, United States
- Study site — Ann Arbor, Michigan, United States
- Study site — East Windsor, New Jersey, United States
- Study site — Stony Brook, New York, United States
- Study site — Winston-Salem, North Carolina, United States
- Study site — Murfreesboro, Tennessee, United States
- Study site — Dallas, Texas, United States
- Study site — Norfolk, Virginia, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.